Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
Reset 

IntegriCulture Inc. Closes Series A Fundraising Round Led by Beyond Next Ventures at JPY800 Million

TOKYO, May 28, 2020 /PRNewswire/ -- IntegriCulture Inc. has completed a Series A fundraising round of JPY800 million (USD7.4 million) backed by Beyond Next Ventures, NH Foods, AgFunder and other investors. The cumulative amount raised stands about JPY1.1 billion (USD10.2 million).

Read more ››
By: PR Newswire Association LLC. - 28 May 2020

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., May 27, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today continued to take action in the ongoing response effort to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 28 May 2020
Related companies:  U.S. Food and Drug Administration

Penumbra, Inc. Announces Pricing of Offering of Common Stock

ALAMEDA, Calif., May 27, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the pricing of an underwritten public offering of 753,012 shares of its common stock at a price to the public of $166.00 per share. All of the... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Penumbra, Inc.

NuVasive, Inc. Announces Pricing Of Offering Of $400 Million Of 1.00% Convertible Senior Notes Due 2023

SAN DIEGO, May 28, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering (the "Offering") of $400.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2023 (the "Convertible Notes") in a private placement to qualified institutional... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  NuVasive, Inc.

Ophthalmology Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery

NEW YORK, May 28, 2020 /PRNewswire/ -- Ophthalmology Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery report provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market... Read more ››

By: PR Newswire Association LLC. - 28 May 2020

Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

NEW YORK, May 28, 2020 /PRNewswire/ -- Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report provides the strategists, marketers and senior management with the critical information they need... Read more ››

By: PR Newswire Association LLC. - 28 May 2020

MPX International Announces Delayed Filing of Interim Financial Statements Pursuant to OSC Blanket Instrument 51-502

Read more ››
By: GlobenewsWire - 28 May 2020

Yuyu Pharma Signs Contract for Baseball Field Ad Campaign

SEOUL, South Korea, May 28, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), a Korean pharmaceutical company, recently signed an advertising contract with the Korea Economic Daily, which holds the advertising business... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Yuyu Pharma, Inc.

CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020

HOUSTON, May 27, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has received... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  CNS Network

Thynk Health to Support the ACR's New COVID-19 Data Elements

LEXINGTON, Ky., May 27, 2020 /PRNewswire/ -- COVID-19 has created new challenges for lung cancer screening programs, in many cases, delaying screenings by several months and creating more difficulty for administrative and scheduling teams.

Read more ››
By: PR Newswire Association LLC. - 28 May 2020

Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock

MARLBOROUGH, Mass., May 27, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) completed the concurrent offerings of (i) 29,382,500 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase up to 3,832,500 additional shares of... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Boston Scientific Corporation

PTC Therapeutics, Inc. to Hold Virtual 2020 Annual Meeting of Stockholders

SOUTH PLAINFIELD, N.J., May 27, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that, due to the public health impact of the novel coronavirus (COVID-19) outbreak and governmental restrictions limiting the number of people who may gather together, and to support the... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  PTC Therapeutics, Inc.

India's Liquid Handwash and Shower Gel Market 2018-2025 - Presents Shares by Company, Brand, Sales Channel, Demographic and Tier

DUBLIN, May 27, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 28 May 2020

Coronavirus (COVID-19) Update:  FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

SILVER SPRING, Md., May 27, 2020 /PRNewswire/ -- Today the U.S. Food and Drug Administration took a new step to support the agency's evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are an additional step to ensure the quality of the tests,... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  U.S. Food and Drug Administration

SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

NEW YORK, May 27, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Progenics Pharmaceuticals, Inc. | Lantheus Holdings, Inc.

WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories

SHANGHAI and NEW YORK, May 28, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has been recognized by Life Science Leader for the third year, achieving 2020 CMO Leadership Awards in six criteria... Read more ››

By: PR Newswire Association LLC. - 28 May 2020

bioLytical Receives Funding to Develop 1-Minute COVID-19 Test

Read more ››
By: GlobenewsWire - 27 May 2020
Related companies:  bioLytical Laboratories Inc.

Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19

Read more ››
By: GlobenewsWire - 27 May 2020
Related companies:  Immunomedics, Inc.

Iovance Reports Pivotal Cohort 4 Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel from C-144-01 Clinical Study in Advanced Melanoma

Read more ››
By: GlobenewsWire - 27 May 2020
Related companies:  Iovance Biotherapeutics, Inc.

BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants

Read more ››
By: GlobenewsWire - 27 May 2020
Related companies:  BioCryst Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
to the top ↑